Duke Chairman Juyu Chen from Shengyang Xiehe Group visited Texas Medical Center
Duke Chairman Juyu Chen and three other professors from Shenyang Xiehe Group, China visited MD Anderson Cancer Center at the Texas Medical Center on September 5th and 6th, 2016. During the visit they met with Dr. Dongfeng Tan from MD Anderson Cancer Center and discussed in depth the ascites derived from cancers such as liver cancer, ovarian cancer, and other cancers. U.S.-China Center for Medical Exchange organized the visit. Project manager Dr. Frieda Li headed the project and accompanied the group from the beginning to the end. Chairman Chen and the visitors were pleased with the visit and said it was exceeded their expectation.
During the visit, Dr. Xiaoling Zhang from Xiehe Group presented their experience with and therapeutic efficacy of superantigen Stahylococcal enterotoxin C (SEC) on ascites. With an efficacy of 93% for the elimination of ascites without recurrence, Dr. Tan was impressed with the results. The representatives from both organizations agreed to support the establishment of an Ascites Therapeutic Center for confirmation of SEC’s effects in patients from both China and the US. The China-US Exchange Center and Shenyang Xiehe Group also considered the potential cooperation on and marketing of other products in the US.